Mawdsleys completes NHS Evergreen Sustainable Supplier Assessment

Mawdsleys completes NHS Evergreen Sustainable Supplier Assessment 10th March 2026

We are pleased to have completed the NHS Evergreen Sustainable Supplier Assessment. The Assessment, which is self-assessment and reporting tool, resulted in us receiving a Level 2: Comprehensive net zero targets and reporting for carbon emissions.

The information reported through Evergreen is supporting us to understand our alignment with NHS sustainability priorities and identify those areas in which we need to accelerate progress.

The Evergreen Assessment is one of several NHS initiatives designed to support its net zero and wider sustainability objectives. We are delighted to be supporting the NHS to achieve their net zero and sustainability ambitions, including those set out in the NHS Net Zero Supplier Roadmap.

Other latest news

Penry Price joins Mawdsleys

Mawdsleys is delighted to welcome Penry Price to the company to head up the generic purchasing division (February 2015). Penry, who joins Mawdsleys from Alliance Healthcare, has been appointed to work alongside Gary Winkle, the new Purchasing Director. Penry has many plans for the generic portfolio at Mawdsleys…

Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer. BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…